SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Jackie Robinson

PatientJackie Robinson
Date of birth1974-01-31
IdentifiersMRN HR-ML037-SYN; SSN (made up) 000-37-2286
Document date2026-07-29
AuthorMarcus Delacroix-Hale, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Review after the retina consultation and first eye injections: retinal diagnosis, glucose, blood pressure and kidney medicines. [S]

History of Present Illness

Mr. Robinson returns two days after his first visit, from the retina clinic this morning. Dr. Ostrowski-Lane examined both eyes with dilating drops, used ultrasound to confirm that the right retina is attached behind the blood, and measured the swelling at the center of each retina by OCT. She found proliferative diabetic retinopathy in both eyes with swelling of the macula in both, and bleeding into the gel of the right eye, and gave the first aflibercept injections in both eyes. His eyes are a little sore, as expected. He had no flashes or curtain over his vision. He asked how quickly his sugar should come down, because he wants it fixed at once, and what the injections will do. Chest tightness on stairs is unchanged; the stress test is booked. [S]

ElementDetail
Retina clinicProliferative retinopathy with macular edema in both eyes, right vitreous hemorrhage, retina attached; first injections given
SymptomsMild eye soreness; no flashes or curtain
ChestTightness on stairs unchanged; stress test booked

Review of Systems

SystemResultFinding
EyesPositiveBlurred vision; mild soreness after the injections; no flashes
CardiovascularPositiveChest tightness on stairs, easing with rest; calf pain after a block
EndocrineNegativeNo low blood sugar
PsychiatricPositiveGrieving; sleeps poorly

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1,000 mg oral tablet, one tablet twice daily with mealsOne tablet twice daily with mealsOral route2025-03-03activeS
Insulin glargine 100 units/mL pen, 30 units at bedtime, adjusted by the written plan: 2 units each week while fasting glucose is above 160 mg/dL, and 4 units less for any reading below 70At bedtime, by the gradual titration planSubcutaneous route2025-03-03activeS
Lisinopril 20 mg oral tablet, one tablet dailyOne tablet dailyOral route2025-03-03 to 2026-07-29completedS
Atorvastatin 80 mg oral tablet, one tablet daily (increased from 40 mg at intake)One tablet dailyOral route2026-07-27activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route2025-03-03activeS
Glucagon 3 mg nasal powder, one spray into the nose for severe low blood sugar; may repeat once after 15 minutesAs needed for severe low blood sugarNasal route2026-07-27activeS
Lisinopril 40 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eatingOne tablet daily, with sick-day rulesOral route2026-07-29activeS
Empagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating, and before surgery or a colonoscopy preparationOne tablet daily, with sick-day rulesOral route2026-07-29activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-29Body height180cmS
2026-07-29Body weight103.8kgS
2026-07-29Body mass index (BMI) [Ratio]32kg/m2S
2026-07-29Systolic blood pressure148mm[Hg]S
2026-07-29Diastolic blood pressure90mm[Hg]S
2026-07-29Heart rate82/minS
2026-07-29Respiratory rate16/minS
2026-07-29Body temperature36.6CelS
2026-07-29Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-29Visual acuity best corrected Right eye by ETDRS eye chart35{letters}85 letters is about 20/20; 35 letters is about 20/200LowS
2026-07-29Visual acuity best corrected Left eye by ETDRS eye chart56{letters}85 letters is about 20/20; 55 letters is about 20/80LowS
2026-07-29Macular grid.center subfield thickness by OCT412um200-300 umHighS
2026-07-29Macular grid.center subfield thickness by OCT468um200-300 umHighS

Physical Exam

Vital signs recorded on 2026-07-29; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 148/90, pulse 82; weight 103.8 kg
EyesMild redness at the injection sites; pupils dilated from the retina examination
CardiovascularRegular rhythm; no ankle swelling

Problems

ProblemClinical statusVerificationCodeProvenance
Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arrangedresolvedconfirmed H53.8S — Synthetic presenting finding, superseded by the retinal diagnosis two days later.
Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arrangedactiveconfirmed R07.89S — Synthetic presenting finding, superseded by the coronary diagnosis after the stress test.
Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%)activeconfirmed E11.65S — Synthetic modern episode linked to his documented diabetes.
Proliferative diabetic retinopathy in both eyes with center-involving diabetic macular edema (central subfield 412 microns right, 468 left); best-corrected acuity 35 letters right and 56 letters leftactiveconfirmed E11.3513S — Synthetic retinal findings anchored to his documented loss of vision.
Vitreous hemorrhage in the right eye from proliferative retinopathy; retina attached on ultrasoundactiveconfirmed H43.11S — Synthetic finding.
Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg)activeconfirmed I12.9S — Synthetic modern episode linked to his documented high blood pressure.
Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79activeconfirmed E11.22S — Synthetic kidney findings.
Chronic kidney disease G2 A2activeconfirmed N18.2S — Synthetic kidney finding.
Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulsesactiveconfirmed E11.51S — Synthetic modern episode linked to the documented artery damage in his legs.
Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testingactiveconfirmed E11.42S — Synthetic modern episode linked to the documented nerve damage in his legs.
History of two mild strokes a year ago, without lasting weaknessactiveconfirmed Z86.73S — Synthetic modern coding of the documented strokes.
Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dLactiveconfirmed E78.5S — Synthetic laboratory finding.
Bereavement: his eldest son died in a car crash six weeks agoactiveconfirmed Z63.4S — Synthetic modern coding of a documented loss; grief is treated as grief, not as a disorder.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure (seated, two readings, large cuff)Every visitCompleted today148/90
ExaminationWeight and BMIEvery visitCompleted today103.8 kg, BMI 32.0
ImagingRetina care: acuity, OCT, injections and laserMonthly at the retina clinic while treatingCompleted todayRetina clinic today: acuity 35 letters right and 56 left; central subfield 412 and 468 microns; first injections both eyes
LaboratoryHemoglobin A1cEvery 3 months while not at goal or after a changeUp to date10.4% two days ago; next at three months
Self-managementGlucose log and low blood sugar review (talking meter)Every visitCompleted todayReadings 170 to 260 mg/dL; no lows; talking meter ordered
LaboratoryPotassium, creatinine and eGFRTwo to four weeks after starting or increasing an ACE inhibitor or SGLT2 inhibitor; then every 6 to 12 monthsOrderedLisinopril increased and empagliflozin started today; check in four weeks
LaboratoryUrine albumin-to-creatinine ratioThree to six months after a treatment change; then 1 to 4 times a year by riskUp to date86 mg/g two days ago, raised also last year; next at three months
LaboratoryLipid panel4 to 12 weeks after starting or changing a statin; then yearlyDueAtorvastatin increased to 80 mg two days ago; due in 4 to 12 weeks
Medication safetyMedicine safety: low blood sugar, sick-day rules, genital infection, dizziness, costEvery visitCompleted todaySick-day rules for empagliflozin and lisinopril written in large print; genital hygiene advice; glucagon shown
ReferralRetina consultationWithin 48 hours for new floaters and vision loss with diabetesCompleted todaySeen by Dr. Ostrowski-Lane today

Goal progress:

Guideline basis: 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026); 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026 (2026); Diabetic Retinopathy Preferred Practice Pattern (2025); Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) (2016); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, ischemic heart disease, chronic kidney disease and depression monographs (2026)

Follow-up: Stress test as booked. Second injections and review in four weeks with potassium and creatinine and the ankle-brachial index. Call for a curtain over the vision, flashes, eye pain with redness, chest pain at rest, dizziness, or vomiting (hold empagliflozin and lisinopril that day). Next scheduled visit 2026-08-26: four weeks after the new medicines: potassium and creatinine, blood pressure, ankle-brachial index, feet, mood, and the second eye injections. [S]